Why is persistent hoarseness for 3 weeks a red flag in general practice?

Persistent hoarseness is the most common presenting symptom of laryngeal squamous cell carcinoma. Glottic cancer presents early with hoarseness because the vocal folds vibrate with every breath — this makes it detectable before it spreads to lymph nodes. The window to diagnose early-stage laryngeal cancer, when five-year survival exceeds 90%, depends entirely on prompt laryngoscopy. The AAO-HNS guideline and Cancer Council Australia Optimal Care Pathway both state that hoarseness exceeding three to four weeks in any adult requires ENT referral. Waiting longer risks a later-stage diagnosis with worse outcomes and more extensive surgery or chemoradiation.

What are the common benign causes of chronic hoarseness?

Vocal cord nodules (bilateral, common in voice professionals — teachers, singers, call-centre workers), vocal cord polyps (often unilateral, linked to smoking or voice strain), laryngopharyngeal reflux (morning hoarseness, throat-clearing), muscle-tension dysphonia (strained voice without structural lesion, linked to stress and voice overuse), hypothyroidism (cord oedema producing low-pitched hoarseness), Reinke's oedema (heavy smoking, characteristic low-pitched gruff voice in women), and presbylaryngis (age-related cord atrophy in older adults). Inhaled corticosteroid use without rinsing can cause candida laryngitis, producing a breathy or rough voice.

Should I start a proton pump inhibitor empirically for presumed reflux-related hoarseness?

The AAO-HNS 2018 guideline recommends against starting empirical PPI before laryngoscopy in patients with hoarseness. The main risk is delaying laryngoscopy by attributing the hoarseness to reflux when an underlying structural cause — including malignancy — is responsible. The appropriate approach is to refer for ENT laryngoscopy first, then trial PPI for eight to twelve weeks if laryngopharyngeal reflux features are confirmed on the scope or clinically. If PPI provides no benefit at twelve weeks, deprescribe rather than continue indefinitely.

How is voice therapy delivered and funded in Australia?

Voice therapy is delivered by a speech pathologist trained in voice disorders. It typically involves four to twelve weekly sessions covering vocal hygiene education, breath support retraining, reduction of compensatory tension, and modified resonance techniques. In Australia, it is funded under a GP Management Plan and Team Care Arrangement (or from 2025 the GP Chronic Condition Management Plan) via MBS item 10970, which covers allied health sessions including speech pathology. Up to five combined allied health sessions per calendar year are available under CDM arrangements. Voice professionals (singers, teachers) may access private speech pathology for longer courses.

What causes vocal cord paralysis and how is it managed?

Vocal cord paralysis results from injury to the vagus nerve or its recurrent laryngeal branch. Causes include thyroid surgery (most common iatrogenic cause), lung cancer at the left apex (left recurrent laryngeal nerve runs under the aortic arch), mediastinal masses, aortic aneurysm, idiopathic, neurological conditions (MS, ALS, Parkinson's disease), and post-intubation injury. Management begins with speech therapy for six to twelve months, since spontaneous recovery is possible for up to twelve months. If paralysis is permanent and the voice is functionally limiting, injection medialisation or surgical type-I thyroplasty provides lasting improvement.

Chronic dysphonia (hoarseness >3 weeks)

Chronic dysphonia: the 3-week laryngoscopy rule and AU GP management

By Dr HB Lo, FACRRM Reviewed 12 October 2026 11 min read

Dysphonia (hoarseness) persisting beyond three weeks in any adult requires ENT laryngoscopy to exclude laryngeal cancer — this is a non-negotiable GP rule. Refer by four weeks; refer earlier if there is dysphagia, unexplained otalgia, a neck mass, weight loss, stridor, or haemoptysis.

Most chronic hoarseness is benign: vocal cord nodules, laryngopharyngeal reflux, muscle-tension dysphonia, or hypothyroidism. Voice therapy (speech pathology), smoking cessation, reflux management, and thyroxine replacement address the common causes.

Laryngeal cancer affects approximately 600 Australians per year, strongly linked to smoking and alcohol. Early laryngoscopy is the only reliable safety net.

Dysphonia — any abnormal voice quality, pitch, loudness, or effort that impairs communication — is one of the most common ENT presentations in general practice. The term “hoarseness” describes the same spectrum and is used interchangeably with dysphonia in clinical practice (AAO-HNS 2018).

Lifetime prevalence is approximately 30%; point prevalence ~6% (Cohen Laryngoscope 2012). Voice professionals — teachers, singers, clergy, call-centre and sales staff — carry a disproportionate burden, with lifetime prevalence in teachers estimated at ~50%.

The threshold that separates routine from urgent is three weeks of persistent hoarseness. Acute laryngitis from an upper respiratory tract infection is self-limiting in under two weeks. Any hoarseness persisting beyond three weeks in an adult mandates ENT referral for laryngoscopy within four weeks — this is the primary general practice safety rule, endorsed by the AAO-HNS guideline, the Cancer Council Australia Optimal Care Pathway for Head and Neck Cancer, and eTG. The purpose is to exclude laryngeal and hypopharyngeal squamous cell carcinoma before window-of-opportunity surgery is lost.

Laryngeal cancer affects approximately 600 Australians per year, strongly linked to tobacco and alcohol. Early-stage glottic cancer — caught on prompt laryngoscopy — carries a five-year survival above 90%. Late diagnosis, by contrast, requires far more extensive treatment.

A. Core clinical — the AU general-practice framework

Differential diagnosis by mechanism

The mechanistic differential guides both the referral urgency and the initial workup.

Category	Examples	Key GP cues
Structural — malignant	Glottic/supraglottic SCC, hypopharyngeal SCC, laryngeal papilloma (HPV)	Smoker or drinker, age >40, weight loss, dysphagia, otalgia, neck mass, haemoptysis
Structural — benign	Vocal cord nodules (bilateral, voice-professional), polyps (unilateral, often smoker), cysts, Reinke’s oedema (heavy smoker), granuloma, presbylaryngis (age-related atrophy)	Gradual onset, occupational voice strain, smoker, older age
Functional	Muscle-tension dysphonia (MTD), paradoxical vocal fold movement	Strained or fluctuating voice, normal cords on scope, linked to stress
Neurogenic	Vocal cord paralysis (vagus/recurrent laryngeal injury), spasmodic dysphonia, Parkinson’s disease (hypokinetic dysarthria), essential tremor	Stridor, aspiration, recent neck or chest surgery, neurological signs
Inflammatory / infectious	Acute laryngitis (viral), chronic laryngitis (smoking, LPR), candida laryngitis (inhaled corticosteroid without rinsing), TB, syphilis	ICS use without rinsing, immunocompromise
Endocrine	Hypothyroidism (cord oedema), acromegaly	Other thyroid symptoms, weight change, fatigue
Iatrogenic	Post-intubation injury, post-radiation, ICS-related candida, ACE inhibitor cough	Recent anaesthetic, ICS use, radiation history
Psychogenic	Conversion aphonia, functional dysphonia	Sudden onset after stressor, normal cough and laugh, normal scope

History

Take a structured voice history covering:

Onset and duration — sudden (haemorrhage, conversion) vs gradual (cancer, nodules, presbylaryngis); duration >3 weeks mandates urgent referral
Pattern — constant vs intermittent; morning hoarseness with throat-clearing (laryngopharyngeal reflux); worse with voice use (nodules, overuse)
Voice use — occupation (teacher, singer, clergy, call-centre), recent unusual vocal load (sporting events, performance)
Risk factors — current and ex-smoking (pack-years), alcohol use, HPV (sexual history), occupational exposures (asbestos, paint fumes, sawdust)
Associated symptoms — dysphagia, odynophagia, otalgia (referred pain from hypopharynx or larynx is a red-flag), neck mass, unintentional weight loss, dyspnoea, stridor, aspiration, heartburn, globus, chronic cough, throat-clearing
Medications — inhaled corticosteroids (candida if not rinsed), ACE inhibitors (cough with laryngeal irritation), antipsychotics (dystonia), anticholinergics (mucosal drying)
Surgical and medical history — thyroid surgery, neck or chest surgery, aortic arch repair, intubation history, prior radiation, thyroid disorders, GORD, MS, Parkinson’s disease, prior malignancy

Examination

Voice quality — note: breathy (cord paralysis or atrophy), strained or strangled (adductor spasmodic dysphonia), rough or irregular (mass lesion), low-pitched (Reinke’s oedema, hypothyroidism), tremor (essential tremor or Parkinson’s)
Neck — palpate thyroid (enlargement, nodules) and cervical lymph nodes (levels I–VI); examine for scars indicating prior thyroid or neck surgery
Oral cavity and oropharynx — leukoplakia, erythroplakia, tonsillar lesions, candida plaques
Cranial nerves — full screen; emphasis on CN IX/X (palate elevation, gag), XI (shoulder shrug), XII (tongue protrusion)
Respiratory — auscultate for stridor; left-sided vocal cord paralysis may accompany an apical left lung lesion
Skin — features of hypothyroidism (myxoedema, delayed reflexes), acromegaly

Investigations — GP tier

Laryngoscopy is not a GP-tier investigation in Australia — refer ENT for flexible nasendoscopy ± stroboscopy. GP investigations:

TFT (TSH + free T4, MBS 66719) — hypothyroidism mimics chronic dysphonia
FBC (MBS 65070) — anaemia suggesting malignancy or chronic disease
Glucose/HbA1c — diabetes as risk factor for candida laryngitis
CT neck + chest with contrast (MBS 56235/56807) — when vocal cord paralysis is identified, to trace the recurrent laryngeal nerve from skull base to aortic arch (left) or thoracic inlet (right); also for suspected neck mass or red-flag presentations
MRI neck/skull base — if cranial nerve lesion is suspected at the jugular foramen

B. The laryngoscopy-first principle and the empirical PPI controversy

Laryngoscopy by 4 weeks — no exceptions

The AAO-HNS 2018 guideline makes a strong recommendation for laryngoscopy by four weeks in any adult with hoarseness persisting ≥3 weeks. The Cancer Council Australia OCP for Head and Neck Cancer is concordant. Earlier referral — within one to two weeks — is appropriate when any of the following are present: dysphagia, unexplained otalgia, neck mass or lymphadenopathy, unintentional weight loss, stridor, haemoptysis, or a voice-professional with a career-threatening change.

The historical practice of “wait until 6 weeks if no red flags” is no longer supported. Missing early laryngeal cancer at the three-to-four-week window is a well-documented sentinel event.

Empirical PPI — after or alongside laryngoscopy, not before

A common pragmatic response to chronic hoarseness in Australian general practice has been an empirical PPI trial, on the assumption that laryngopharyngeal reflux (LPR) is responsible. The AAO-HNS 2018 guideline recommends against initiating empirical PPI before laryngoscopy in patients with hoarseness, because: (1) multiple RCTs show only modest benefit over placebo for LPR-attributed hoarseness; and (2) starting PPI can provide false reassurance, delaying the laryngoscopy that is the only reliable way to exclude malignancy.

The appropriate sequence: refer for ENT laryngoscopy first. If laryngoscopy confirms LPR features, trial PPI for 8–12 weeks alongside lifestyle measures (head-of-bed elevation, late-meal avoidance, weight loss if overweight, alcohol and tobacco cessation). Review at 12 weeks and deprescribe if no benefit — long-term PPI without documented indication is not appropriate.

The Reflux Symptom Index (RSI ≥13) and Reflux Finding Score (RFS ≥7) — Belafsky tools 2002 — are useful structuring frameworks for LPR assessment but have poor specificity and should be interpreted alongside laryngoscopic findings, not as stand-alone diagnostic criteria.

C. Management by diagnosis

Vocal cord nodules

Voice therapy with a speech pathologist (4–12 sessions, MBS 10970 under CDM) is first-line — per AAO-HNS 2018, over 50% of nodules resolve with voice therapy and vocal hygiene alone without surgery. Treat coexisting LPR. Microlaryngoscopic excision is reserved for nodules refractory to adequate voice therapy.

Reinke’s oedema

Smoking cessation is the most critical intervention — oedema typically regresses or stabilises after cessation. Voice therapy for residual dysphonia. Microlaryngoscopic reduction surgery if oedema is severe or if there is airway compromise.

Laryngopharyngeal reflux and chronic laryngitis

PPI standard dose (omeprazole 20 mg, esomeprazole 20–40 mg, pantoprazole 40 mg, or lansoprazole 30 mg) for 8–12 weeks, alongside lifestyle modifications per reflux management. If no improvement, re-scope before extending treatment — alternative diagnoses must be excluded. Per the NHMRC alcohol guideline, target fewer than two standard drinks per day for general health and reflux reduction.

Vocal cord paralysis

Begin voice therapy (6–12 months): spontaneous recovery is possible for up to 12 months from onset. CT from skull base to aortic arch is mandatory to identify a treatable cause (lung cancer, thyroid malignancy, lymphoma). If paralysis persists beyond 12 months with functional voice limitation, injection medialisation (hyaluronic acid, hydroxylapatite) or type-I thyroplasty provides durable improvement.

Spasmodic dysphonia

Botulinum toxin injection to the thyroarytenoid muscle every 3–6 months is the established treatment. The Cochrane Wei 2019 review supports efficacy. PBS-funded under the spasmodic dysphonia Authority indication; specialist (laryngology or neurology) prescribed and administered.

Hypothyroidism

Levothyroxine titrated to TSH. Reassess voice 3–6 months after achieving euthyroid status — cord oedema typically resolves with normalisation of thyroid function.

Counsel rinse and spit after every inhaled corticosteroid dose, with spacer use. First-line treatment is nystatin oral suspension. Oral fluconazole if topical therapy fails or the candida is extensive. Do not deprescribe the ICS without specialist review — asthma or COPD control takes precedence over the laryngeal side effect, which is preventable with correct technique.

Laryngeal and hypopharyngeal cancer

Urgent multidisciplinary team oncology referral. Treatment is surgery (transoral laser microlaryngoscopy for early glottic cancer; open laryngectomy for advanced), radiation, chemoradiation, or immunotherapy for advanced or metastatic disease. Early-stage (T1–2N0) glottic SCC has five-year survival >90%; advanced disease substantially lower. Expedited referral pathway under the Cancer Council OCP for Head and Neck Cancer.

D. Australian operations

MBS items

Item	Purpose
23 / 36 / 44	Standard GP consultation; adequate workup typically Level C/D
91790 / 91801	GP telehealth video/phone equivalents — suitable for follow-up post-laryngoscopy
66719	TFT (TSH + free T4)
65070	FBC
10970	Speech pathology under CDM (5 sessions/year combined allied health)
132 / 133	Specialist/consultant initial/subsequent — ENT
715	ATSI annual health assessment — includes opportunistic voice and oral health screen
56235 / 56807	CT neck (with contrast) / CT chest — radiologist-billed; verify codes

PBS

PPIs (omeprazole, esomeprazole, pantoprazole, rabeprazole, lansoprazole) — General Schedule; used for LPR (off-label indication, standard practice)
Levothyroxine — General Schedule
Nystatin oral suspension, fluconazole — General Schedule; ICS-related candida
Botulinum toxin type A — PBS Authority under “spasmodic dysphonia” indication; specialist-prescribed

Referral pathways

ENT (otolaryngologist) — all hoarseness >3 weeks; public or private depending on red flags, voice-professional status, and patient circumstances
Laryngology subspecialty — voice professionals, spasmodic dysphonia, refractory or complex cases (major centres: Sydney, Melbourne, Brisbane, Perth)
Speech pathology — voice therapy 4–12 sessions under CDM MBS 10970, or private; ASOHNS directory for specialist voice clinicians
Neurology — vocal cord paralysis with neurological features, spasmodic dysphonia diagnosis, Parkinson’s-associated dysphonia (LSVT LOUD programme)
Oncology MDT — confirmed laryngeal or hypopharyngeal cancer
Endocrinology — refractory hypothyroidism, acromegaly
Workers’ compensation pathway — occupational voice disorders (teachers, call-centre workers); allied health assessment and workplace accommodation report

E. Special populations

Voice professionals

Teachers, singers, clergy, performers, and call-centre staff have a disproportionate burden of vocal cord pathology and a career-critical stake in voice preservation. Expedite ENT referral — do not wait the full three-week threshold if symptoms are already limiting occupational function. Refer to a speech pathologist with performance-voice experience early, even before the ENT appointment. Provide workplace accommodations: amplification (microphone), reduced contact hours, vocal rest periods, and hydration access. Occupational history documentation is essential for any workers’ compensation pathway.

Older adults — presbylaryngis

Presbylaryngis — age-related vocal cord atrophy with bowing and glottic gap — is common in adults over 70, producing a thin, weak, or breathy voice. Voice strengthening therapy with a speech pathologist is the primary intervention. Injection medialisation is an option for severe glottic gap causing significant functional impairment or aspiration. Cancer remains on the differential even in older adults — do not attribute hoarseness to age alone without laryngoscopy.

Aboriginal and Torres Strait Islander communities

Smoking prevalence is higher in ATSI communities, driving a higher laryngeal cancer risk and, historically, later-stage presentation. Use the ATSI 715 annual health assessment as an opportunistic case-finding tool for hoarseness. Engage Aboriginal Medical Services and Aboriginal Community Controlled Health Organisations (ACCHS) pathways for referral coordination and culturally safe follow-up. ENT outreach clinics through the Royal Flying Doctor Service and regional networks are available in many areas.

Rural and remote patients

ENT laryngoscopy access is very limited in rural and remote Australia. Emerging models include video flexible nasendoscopy and telehealth specialist review. MBS telehealth items 91790/91801 support GP follow-up. Use GP referral letters that clearly document hoarseness duration, smoking history, and red flags to fast-track ENT triage through regional outreach services.

When to escalate

Refer or escalate urgently when:

Hoarseness >3 weeks in any adult — routine ENT referral by 4 weeks
Any red flag (dysphagia, unexplained otalgia, neck mass, weight loss, haemoptysis, stridor) — urgent ENT within 1–2 weeks
Stridor or dyspnoea — potential airway emergency; consider ED, call 000 if acute
Suspected vocal cord paralysis with no clear cause — urgent CT and ENT
Voice professional with sudden or career-threatening change — expedited ENT (days, not weeks)
Suspected laryngeal or hypopharyngeal cancer on laryngoscopy — urgent oncology MDT

What this article is and is not

This is general health information drawn from current guidelines including Therapeutic Guidelines, the AAO-HNS Clinical Practice Guideline for Hoarseness (Stachler 2018), the Cancer Council Australia Optimal Care Pathway for Head and Neck Cancer, and RACGP guidelines. It is not personal medical advice and does not create a doctor–patient relationship. Decisions about investigation, referral, and treatment are made with your own GP and treating clinicians.

For consumer information: HealthDirect — Hoarse voice, Better Health Channel — Voice disorders.

Sources cited

Frequently asked questions

Why is persistent hoarseness for 3 weeks a red flag in general practice?

Persistent hoarseness is the most common presenting symptom of laryngeal squamous cell carcinoma. Glottic cancer presents early with hoarseness because the vocal folds vibrate with every breath — this makes it detectable before it spreads to lymph nodes. The window to diagnose early-stage laryngeal cancer, when five-year survival exceeds 90%, depends entirely on prompt laryngoscopy. The AAO-HNS guideline and Cancer Council Australia Optimal Care Pathway both state that hoarseness exceeding three to four weeks in any adult requires ENT referral. Waiting longer risks a later-stage diagnosis with worse outcomes and more extensive surgery or chemoradiation.
What are the common benign causes of chronic hoarseness?

Vocal cord nodules (bilateral, common in voice professionals — teachers, singers, call-centre workers), vocal cord polyps (often unilateral, linked to smoking or voice strain), laryngopharyngeal reflux (morning hoarseness, throat-clearing), muscle-tension dysphonia (strained voice without structural lesion, linked to stress and voice overuse), hypothyroidism (cord oedema producing low-pitched hoarseness), Reinke's oedema (heavy smoking, characteristic low-pitched gruff voice in women), and presbylaryngis (age-related cord atrophy in older adults). Inhaled corticosteroid use without rinsing can cause candida laryngitis, producing a breathy or rough voice.
Should I start a proton pump inhibitor empirically for presumed reflux-related hoarseness?

The AAO-HNS 2018 guideline recommends against starting empirical PPI before laryngoscopy in patients with hoarseness. The main risk is delaying laryngoscopy by attributing the hoarseness to reflux when an underlying structural cause — including malignancy — is responsible. The appropriate approach is to refer for ENT laryngoscopy first, then trial PPI for eight to twelve weeks if laryngopharyngeal reflux features are confirmed on the scope or clinically. If PPI provides no benefit at twelve weeks, deprescribe rather than continue indefinitely.
How is voice therapy delivered and funded in Australia?

Voice therapy is delivered by a speech pathologist trained in voice disorders. It typically involves four to twelve weekly sessions covering vocal hygiene education, breath support retraining, reduction of compensatory tension, and modified resonance techniques. In Australia, it is funded under a GP Management Plan and Team Care Arrangement (or from 2025 the GP Chronic Condition Management Plan) via MBS item 10970, which covers allied health sessions including speech pathology. Up to five combined allied health sessions per calendar year are available under CDM arrangements. Voice professionals (singers, teachers) may access private speech pathology for longer courses.
What causes vocal cord paralysis and how is it managed?

Vocal cord paralysis results from injury to the vagus nerve or its recurrent laryngeal branch. Causes include thyroid surgery (most common iatrogenic cause), lung cancer at the left apex (left recurrent laryngeal nerve runs under the aortic arch), mediastinal masses, aortic aneurysm, idiopathic, neurological conditions (MS, ALS, Parkinson's disease), and post-intubation injury. Management begins with speech therapy for six to twelve months, since spontaneous recovery is possible for up to twelve months. If paralysis is permanent and the voice is functionally limiting, injection medialisation or surgical type-I thyroplasty provides lasting improvement.

Source quality

Sources grouped by evidence tier. AU primary tier first; international where AU is silent or lagging; named-author reconstruction where guidelines have not yet caught up. How tiers work.